DIH Dedicated to restoring mobility and Enhancing human performance Investor Presentation August 2024 Nasdaq: DHAI
In this presentation, “DIH”, the “Company”, “we”, “us” and “our” mean DIH Holding US, Inc, a Delaware corporation (Nasdaq: DHAI). All amounts are in U.S. dollars unless otherwise indicated. The information contained herein does not purport to contain all of the information about the Company. The information contained herein has not been independently verified. No representations or warranties are made or implied with respect to the information contained herein. This presentation contains forward-looking statements with respect to the Company. These forward-looking statements, by their nature, require the Company to make certain assumptions and necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements, including without limitation the successful and timely completion and the commercialization of the products referred to herein. Forward-looking statements are not guarantees of performance. These forward-looking statements, including financial outlooks and strategies or deliverables stated herein, may involve, but are not limited to, comments with respect to the Company’s business or financial objectives, its strategies or future actions, its targets, expectations for financial condition or outlook for operations. Words such as “may”, “will”, “would”, “could”, “expect”, “believe”, “plan”, “anticipate”, “intend”, “estimate”, “continue”, or the negative or comparable terminology, as well as terms usually used in the future and conditional, are intended to identify forward-looking statements. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. These assumptions are considered to be reasonable based on currently available information, but the reader is cautioned that these assumptions regarding future events, many of which are beyond its control, may ultimately prove to be incorrect since they are subject to risks and uncertainties that affect the Company and its business. The forward-looking information set forth therein reflects expectations as of the date hereof and is subject to change thereafter. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Undue reliance should not be placed on forward-looking statements. The forward-looking statements contained in this presentation are expressly qualified by this cautionary statement. This presentation is not intended to form the basis of any investment decision and there can be no assurance that any transaction will be undertaken or completed in whole or in part. The delivery of this presentation shall not be taken as any form of commitment on the part of the Company or its stockholders to proceed with any transaction, and no offers will subject the Company or its stockholders to any contractual obligations before definitive documentation has been executed. The Company reserves the right at any time without prior notice and without any liability to (i) negotiate with one or more prospective investors in accordance with any timetable and on any terms that the Company may decide, (ii) provide different information or access to information to different prospective investors, (iii) enter into definitive documentation and (iv) terminate the process, including any negotiations with any prospective investor without giving any reasons therefor. Investor presentation forward looking statement and disclaimer Page 2
DIH at a glance: Robotic-enabled movement platform improving the lives of people with disabilities and functional impairments
Investor presentation total solution provider in neuro-rehabilitation and human performance research Improving lives by providing human movement therapy while empowering leading scientists and clinics to study balance and movement disorders through Advanced Technology. Page 4
Investor presentation addressing increased market demand by providing innovative solutions for hospitals, clinics, and research Institutions DIH – a Global Solution Provider, has the broadest portfolio in neuro-rehabilitation and human performance research, with over 4,500 devices installed. With an aging population and an increasing number of people living with neurological diseases, hospitals and clinics will be understaffed; robotic rehabilitation fills the gap and helps therapists and patients thrive. More intensive, repetition-based therapy, supported by Advanced Technology is shown to have superior patient outcomes and can send them home sooner. Technology solves the supply-demand problem in rehabilitation settings by allowing occupational and physical therapists to work with multiple patients effectively. Bridges the gap between Clinical and Research applications by enabling and inventing the most advanced technological ways to study and treat balance and movement disorders. Page 5
Investor presentation dih at a glance Page 6 Products & Systems 19 $64.5M FY242 Revenue 19% YoY increase USA, Singapore, Chile, Slovenia, Germany 5 Commercial Regions Employees 243 in 9 global locations from 33 nationalities ` Devices installed1 4,500+ 1,500+ Medical device registrations in 75 countries Sites 3 For R&D and manufacturing in CH,NL and USA 1,800 Customer Accounts HQ 1 DIH Holding US $74M - $77M FY25 Revenue Guidance 17% YoY increase3 1 Includes clinical and research install base 2 FY24 year ending March 31, 2024 3 FY25 YoY revenue growth at the midpoint of guidance
Meeting market demands with innovative Advanced Technologies
Patients Neurological Stroke SCI & cerebral palsy Parkinson’s disease Traumatic brain injury Orthopedic Amputation Osteoarthritis Musculoskeletal disorders Geriatric & Pediatric Aging population with an increased risk of falling and functional impairment Pediatric patients with mobility impairments Health Providers Rehabilitation Hospitals Research Facilities Investor presentation market opportunity: end-to-end broad market coverage Page 8 Physical Therapy and Rehab Clinics
Investor presentation integrated solutions for the entire continuum of care across multiple markets Rehabilitation Hospitals and Outpatient Clinics (“Hospital and Clinic Market”) Research & Human Movement Labs* (“Research Market”) ARM & HAND GAIT & BALANCE DATA INTEGRATION C-MILL ANDAGO RYSEN LOKOMAT CAREN DOME CAREN EXTENDED GRAIL M-GAIT ARMEO POWER ARMEO SPRING / SPRING PRO ARMEO SENSO Page 9 3 1 Two product lines available 2 Product line consists of three products 3 Prototype available; In development . 2 1 *Motek products are currently being sold by DIH through an exclusive relationship between Motek and DIH SAFEGAIT1 ERIGO1
Investor presentation global trEnds and MARKET DRIVERS Page 10 Aging population Advanced Technology is key to meeting market demands. Increasing neurological disorders and related disabilities Need of care and lack of therapist 1 WHO: Ageing and Health; https://www.who.int/news-room/fact-sheets/detail/ageing-and-health 2 United Nations: Aging and Disability; https://www.un.org/development/desa/disabilities/disability-and-ageing.html 3 https://pubmed.ncbi.nlm.nih.gov/36902495/ 4 NCBI: Causes and Trends of Disabilities in Community-Dwelling Stroke Survivors: A Population-Based Study; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833459/ 5 WHO: Rehabilitation; https://www.who.int/news-room/fact-sheets/detail/rehabilitation#:~:text=Globally%2C%20an%20estimated%202.4%20billion,and%20characteristics%20of%20the%20population. 6 2020: World Physio: https://world.physio/sites/default/files/2021-02/AMC2020-Europe.pdf // WHO: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3408; https://www.theglobaleconomy.com/rankings/physiotherapists_per_1000_people/ >1B Members of a growing elderly population, worldwide1 38%+ of stroke survivors were found to have disabilities4 46%+ of the world's aging population has disabilities2 1.09 physiotherapists per 1,000 people6 Est. 2.4B People are currently living with a health condition that may benefit from rehabilitation5 Est.15% of the global population is affected by neurological disorders3
Investor presentation CONTINUUM OF CARE FOR Upper extremities REHABILITATION ARMEO®SENSO ARMEO®SPRING PRO & ARMEO®SPRING ARMEO®POWER ROBOTIC ARM MOVEMENT SUPPORT TRAINING PATIENT NEEDS PATIENT ABILITY (MMT) MMT 0 MMT 1 MMT 2 MMT 3 MMT 4 MMT 5 ARM WEIGHT SUPPORT TRAINING SELF-DIRECTED TRAINING MMT: Manual Muscle Test for shoulder and/or elbow; MMT 2 for Armeo Senso =with arm weight support Page 11
PATIENT ABILITY (FAC) Investor presentation continuum of CARE FOR LOWER EXTREMITIES REHABILITATION C-MIll Andago® rysenTM LOKOMAT® ERIGO® FAC 0 FAC 1 FAC 2 FAC 3 FAC 4 FAC 5 SAFEGAIT* MOBILIZATION AND VERTICALIZATION REPETITIVE, PHYSIOLOGICAL GAIT TRAINING OVERGROUND GAIT AND BALANCE TRAINING GAIT ADAPTABILITY TRAINING OVERGROUND BODY WEIGHT SUPPORT PATIENT NEEDS FAC: Functional Ambulation categories Page 12 * Available only in the USA
Investor presentation research PORTFOLIO Page 13 Caren extended* GRAIL* M-GAIT* Modular Gait Lab Caren high end* Targets all aspects of balance and locomotion. The use of virtual reality enables researchers to assess the subject’s behavior and includes sensory inputs like visual, auditory and vestibular. Provides analysis and therapy in challenging conditions to improve gait, while real-time feedback enables analysis and training during the same session. Enables multiple system enhancements for added functionality of gait-lab. INTENDED USE Gait Real-time Analysis Interactive Lab Computer Assisted Rehabilitation Environment Computer Assisted Rehabilitation Environment *Motek products are currently being sold by DIH through an exclusive relationship between Motek and DIH
Investor presentation A trusted partner every step of the way We provide guidelines and support customers in building their rehabilitation project. We find the right solution to match the organizations’ needs, space and budget. BUSINESS MODEL and PLANNING To help make the best use of our solutions, we offer clinical integration consulting and ongoing support, as well as education and training. CLINICAL SERVICES We provide technical support and regular maintenance after installation so customers can maintain clinical routines without disruption. TECHNICAL SERVICES Research drives us forward and our support and services help institutions initiate their own research programs. RESEARCH SERVICES Customers immediately stand out from other rehabilitation facilities. With our support we make sure they are seen and heard. MARKETING SERVICES DIH provides a broad portfolio of devices and an extensive range of services, to become a Total Solution partner for our customers Page 14
Investor presentation trusted by leading rehabilitation and research institutions >60 Leading Institutions trust DIH DIH collaborates with world renowned institutions in rehabilitation and research as reference centers and innovation partners Page 15
C-Mill 70* GRAIL & M-Gait 234* Investor presentation Market leading product investigation as evidenced by ToTAL number of publications1 Page 16 1The Knowledge Platform includes all research articles, conference proceedings, and theses available on our devices and can be accessed via knowledge.hocoma.com and knowledge.motekmedical.com 2 Reviewed and evaluated by a group of experts in the field before the article is published. *Motek Products are currently being sold by DIH through an exclusive relationship between Motek and DIH LOKOMAT 610 ARMEO LINE 217 ERIGO 60 CAREN 204* >1,300 Published Publications >1,000 publications in peer-reviewed2 journals 40+ ongoing studies
Early Entrants Emerging Players Industry Leader DIH is uniquely positioned as a leader in rehabilitation-tech and research markets Investor presentation Competitive Landscape Page 17 LFWD (NASDAQ) EKSO (NASDAQ) DVL (ASX) DHAI (NASDAQ)
Investor presentation Sources of Competitive Advantage Page 18 Leading Technology Highly recognized premier brands and technologies in our industry, endorsed by leading rehabilitation institutes and opinion leaders Product Portfolio Broadest product portfolio in advanced robotics and sophisticated VR-enabled movement systems; most competitors operate in a single product category Commercial Reach Strong global market coverage with approx. 3-5x more sales volume than competitors Innovation Sustained innovation capabilities with decades of proven expertise and resources Tech Partnerships Platform and core technology (hardware and software) supported by strong partnerships with leading research groups Network Effect Strong supporting functions and operational infrastructure that establish a platform network effect which will be difficult to replicate Industry Experience Organizational breadth and depth with significant experience in acquisition integration; key to our growth strategy and differentiation from competitors that are early in their organizational life cycles
Page 19 Global solution provider combining innovative robotic and VR technologies with clinical integration and proprietary insights. Transformative total solutions provider and consolidator in a fragmented and manual-labor-driven industry. Innovative and broad product portfolio, covering the entire continuum of care. Strong growth opportunity with $64.5M revenue in FY24, representing 19% year-over-year growth. Investor presentation Investment highlights $14.9B1 Total global rehabilitation equipment market ~$590M1 Rehabilitation Robots Market ~27%1 Estimated market CAGR through 2027 1 “Rehabilitation Robots Market by Product, End user and Geography – Forecast and Analysis (2023 – 2027)” November 2022 Global Market
Way Forward - Investment Opportunity
High manual therapies costs are primed for disruption across care centers Robotic solutions provide value and save costs, creating flexibility within institutional budgets Investor presentation Transforming the rehabilitation care model Page 21 Rehab Hospitals Long-Term Care & Skilled Nursing Facilities Outpatient Clinics Acute Rehab $50B in manual therapies costs1 1 Grandview Research, October 14, 2022
Phase 3 Phase 2 Penetrate Markets Drive Market Standardization Develop Total Solutions Expand presence in US and EU Prioritize product innovation and integration efforts Enter new institutions Further penetrate existing accounts Leverage global platforms and infrastructure Realize economies of scale Execute strong M&A targeting Provide fully supported product ecosystems Create significant value and cost savings for providers Enhance the therapy business model Phase 1 Investor presentation Strategic Growth Page 22
Financial Highlights
Page 24 Investor presentation Strong revenue growth and market penetration $64.5M Revenue, +19% YoY growth 79% devices 17% services 4% other ($8.4M) Net Loss 46% Gross Margin $5.2M Cash Flow from Operations Fiscal Year 2024 Fiscal Year 2025 Revenue Guidance: $74.0M-$77.0M 19% YoY Growth 17% YoY Growth* *FY25 YoY revenue growth at midpoint of guidance $16.2M Revenue, +24% YoY growth 76% devices 22% services 2% other $(0.6M) Net Loss 54% Gross Margin ($2.0M) Cash Flow from Operations First Quarter 2025
Investor presentation DIH executive Officers Page 25 Jason Chen Chief Executive Officer and Chairman of the Board Lynden Bass Chief Financial Officer Dr. Patrick Bruno Chief Market Officer
Investor presentation International management team Page 26 CEO and Chairman of the Board Jason Chen Chief Financial Officer Lynden Bass Chief Market Officer Hospital & Clinic Patrick Bruno Senior Vice President Sales – EMEA Indirect Slavko Skafar Vice President Global Operations Walther Geiger Vice President FP&A and Commercial Operations Finance LaTonya Vincent Vice President Research Frans Steenbrink
Thank you For more information contact investor.relations@dih.com